Conclusion.-Percutaneous stent placement for management of native or recurrent aortic coarctation is an efficient and safe alternative to surgery, and is associated with a long term reduction in blood pressure and LV hypertrophy. Background.-Percutaneous closure of huge and tubular (type C) patent ductus arteriosus remain challenging or unsuccessful in small infants. Aim.-To evaluate the usefulness and safety of Amplatzer vascular plug II and IV for percutaneous closure of very large ductus arteriosus under 6 kg. Methods.-Single-center retrospective study including all consecutive unselected patients (≤ 6 kg, large symptomatic ductus arteriosus) referred to our institution over a 4 years period for percutaneous closure and treated with plug II or IV. No patient was excluded and there was no failure or surgery within the weight limit to consider percutaneous closure (> 2.5 kg).
Background.-Cardiac catheterization procedures are being increasingly performed in children with congenital heart disease for diagnostic and treatment purposes. Given children's greater sensitivity to radiation and the longer life span during which radiation health effects can develop, the ALARA principle (irradiation As Low As Reasonably Achievable) is of peculiar importance. We report the radiation doses and related factors for children who underwent cardiac catheterization procedure in Toulouse children Hospital from January to April 2013. Methods.-We prospectively included 60 children (mean age 4 years old, weight 2.350-59 kgs) undergoing a therapeutic (n = 55, 91.7%) or diagnostic (n = 5, 8.3%) cardiac catheterization procedures. We investigated the relationship between dose area product (DAP), fluoroscopic time (FT), pulsed fluoroscopic DAP, image acquisition DAP, age, morphological parameters and double products combining FT and weight or size or body mass index (BMI) or body surface area (BSA). BSA was calculated according to the Mosteller formula.
Results.-The mean DAP was 20,697 ± 29,342 mgycm 2 . The mean total fluoroscopic time was 24.6 ± 19.7 min. DAP was not significantly different between diagnostic and therapeutic catheterization (P = 0.98). Although image acquisition DAP accounted for only 4.4 ± 2.4% of FT, it represented 42.5 ± 19.6% of DAP. DAP was moderately although significantly correlated with FT (r = 0.73, P < 0.0001), BSA (r = 0.44, P = 0.0011), age (r = 0.37, P = 0.0082), weight (r = 0.43, P = 0.002) and size (r = 0.38, P = 0.0052). DAP was strongly associated with FT × Weight (r = 0.92, P < 0.0001), FT × BSA (r = 0.93, P < 0.0001) and FT × Size (r = 0.91, P < 0.0001). Linear regression analysis model involving FT × BSA to predict DAP was significant (P < 0.0001). Approximately 90% of the variance of DSA was accounted for by this model. Results.-Since creation of the DNA bank, 2364 blood samples have been collected after informed consent of patients and their legal representatives. They are stored in a dedicated space of the institution's general DNA bank. Among them, there are 1299 patients' samples and 1065 samples belonging to parents or relatives. Four hundred and sixteen triple samples (patient and both parents) have been obtained. One hundred and fifty-eight samples come from families with at least two members affected by congenital heart disease. Eighty-eight samples belong to patients without congenital cardiac defects but with other severe cardiac pathologies. Six hundred and fifty-two patient samples (50%) were coded retrospectively. Based on the ACC-CHD classification, ''CARREG'' contains 658 samples (51%) belonging to the group 8 (anomalies of the outflow tract). One hundred and fifty-two samples (12%) were attributed to group 4 (anomalies of the atrioventricular valve). The remaining samples were classified in group 1: 41 (3%), group 2: 22 (2%), group 3: 85 (7), group 5: 31 (2%), group 6: 62 (5%), group 7: 55 (4%), group 9: 95 (7%) and group 10: 9 (1%). Perspectives.-To make international comparison and data exchange easier, cardiac phenotyping in ''CARREG'' relies on IPCCC and the newly developed ACC-CHD. First cooperations with national and international research partner are in progress. The development of a limited access website as communicative platform for researches will be one of the major goals in the near future.
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